Nuclear magnetic resonance –based co-magnetometers are essential tools for applications ranging from inertial navigation to ...
This biotech specializes in clinical-stage therapies for neurological disorders, with a pipeline targeting epilepsy and ...
Elenagen plus gemcitabine improves overall survival in platinum resistant ovarian cancer without increasing toxicity in Phase ...
Funding to support the execution of a Phase 2 proof-of-concept trial of HER-096 in Parkinson’s disease, following completion of study ...
DoD-Funded Study Accelerates Novel PTSD Mechanism into Trials; Proven Alcohol Safety Profile De-Risks Program for ...
14h
Tark Thermal Solutions’ EFC2400 Natural Refrigerant Chiller Aligns with Latest EU F‑Gas Regulation
The EFC2400 leverages nearly a decade of our experience in customer‑specific natural refrigerant systems and packages ...
Executives from Equillium (NASDAQ:EQ) outlined the scientific rationale and near-term development plans for its lead program, EQ504, during a recent fireside chat focused on immunology and ...
Applied physicists in the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have discovered a new way ...
EET Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096 Funding to support ...
Evommune surged 70% after EVO301's Phase 2a data showed rapid, significant EASI reductions in moderate-to-severe atopic ...
MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results